Bivalent vaccine platform based on Japanese encephalitis virus (JEV) elicits neutralizing antibodies against JEV and hepatitis C virus

Directly acting antivirals recently have become available for the treatment of hepatitis C virus (HCV) infection, but there is no prophylactic vaccine for HCV. In the present study, we took advantage of the properties of Japanese encephalitis virus (JEV) to develop antigens for use in a HCV vaccine....

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Sci Rep
Hoofdauteurs: Saga, Ryohei, Fujimoto, Akira, Watanabe, Noriyuki, Matsuda, Mami, Hasegawa, Makoto, Watashi, Koichi, Aizaki, Hideki, Nakamura, Noriko, Tajima, Shigeru, Takasaki, Tomohiko, Konishi, Eiji, Kato, Takanobu, Kohara, Michinori, Takeyama, Haruko, Wakita, Takaji, Suzuki, Ryosuke
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Nature Publishing Group 2016
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4922013/
https://ncbi.nlm.nih.gov/pubmed/27345289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep28688
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items